Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01496729

Transversus Abdominis Plane (TAP) Block After Kidney Transplantation

Single Shot Transversus Abdominis Plane (TAP) Block Versus Sham Block for Analgesia in Donors and Recipients Following Kidney Transplantation

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of California, San Francisco · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Postoperative pain is a major problem in patients who either donate a kidney or undergo kidney transplantation. This pain is commonly treated with opioids, which can cause several side effects, ranging from pruritus, impaired vigilance, and most concerning to severe respiratory depression. This can be aggravated in the recipient by accumulation of opioid metabolites secondary to renal impairment and secretion. Several studies have shown an opioid sparing effect of a transversus abdominis plane (TAP) block after surgery in the lower abdomen. In the proposed study, we plan to compare the impact of an ultrasound guided single shot transversus abdominis plane (TAP) block versus a ultrasound guided sham block with normal saline (placebo) on postoperative pain scores, postoperative opioid consumption, as well as patient's satisfaction. The investigators hypothesize, that patients who receive a TAP block will have lower postoperative pain scores, lower postoperative opioid consumption as well as higher satisfaction scores.

Conditions

Interventions

TypeNameDescription
PROCEDURETransversus abdominis plane (TAP) blockA Transversus abdominis plane (TAP) block with ropivacaine, a local anesthetic, will be performed at the end of the surgical procedure.
PROCEDURESham TAP block with normal salineA sham TAP block with normal saline will be performed at the end of the surgical procedure.

Timeline

Start date
2012-01-01
Primary completion
2012-01-01
Completion
2013-01-01
First posted
2011-12-21
Last updated
2013-10-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01496729. Inclusion in this directory is not an endorsement.